Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Pharmaceutics|July 29, 2023
Dose Optimization and Targeting Strategies of Anti-Infective AgentsMartin Šíma, Ondřej SlanařPrague Medical Report|September 22, 2023
Effects of Cannabidiol in Inflammation: A Review of Pre-clinical and Clinical FindingsMichaela Sklenárová, Martin Šíma, Ondřej SlanařPrague Medical Report|September 15, 2022
Factors Affecting Drug Exposure after InhalationAnežka Nováková, Martin Šíma, Ondřej SlanařPrague Medical Report|October 7, 2019
Pharmacokinetics of DasatinibJana Hořínková, Martin Šíma, Ondřej SlanařFolia Biologica|December 8, 2023
Pathogenesis of Collagen-Induced Arthritis: Role of Immune Cells with Associated Cytokines and Antibodies, Comparison with Rheumatoid ArthritisMonika Šteigerová, Martin Šíma, Ondřej SlanařPharmaceutics|March 6, 2021
What is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?Martin Šíma, Danica Michaličková, Ondřej SlanařPrague Medical Report|December 20, 2021
Therapeutic Drug Monitoring of Protein Kinase Inhibitors in Breast Cancer PatientsJaroslava Roušarová, Martin Šíma, Ondřej SlanařExpert Opinion on Drug Metabolism & Toxicology|December 15, 2020
Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomicsOndřej Slanař, Karolína Hronová, Olga Bartošová, et al.European Journal of Hospital Pharmacy : Science and Practice|November 10, 2021
Levetiracetam pharmacokinetics and its covariates: proposal for optimal dosing in the paediatric populationPavla Pokorná, Martin Šíma, Natálie Švestková, et al.Prague Medical Report|May 18, 2024
Evidence for Therapeutic Drug Monitoring of Atypical AntipsychoticsVeronika Krejčí, Irena Murínová, Ondřej Slanař, et al.Pageof 8